Examination of Cognitive Function in Patients Treated With Subutex
1 other identifier
observational
60
0 countries
N/A
Brief Summary
People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs. The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment. The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2008
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2008
CompletedFirst Posted
Study publicly available on registry
May 30, 2008
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedJanuary 27, 2009
January 1, 2009
7 months
May 27, 2008
January 25, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ASI quationarry, neurocognitive computerized tests, MMSE test, Sexual function questionnaire and satisfaction questionnaire
In 2 visits during the study
Study Arms (1)
Subutex group
People who used opiates and willing to start with subutex treatment
Interventions
Eligibility Criteria
People who suffer from addiction problems (opiates) and willing to start Buprenorphine treatment
You may qualify if:
- People who suffer from addiction problems (opiates)
- People who willing to to start Buprenorphine treatment
- People who willing to cooperate with study tests and questionnaires
- People aged 18 to 70
You may not qualify if:
- People who suffer from any neurocognitive problems
- People who suffer from mental illnesses
- People who are having legal guardian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BeerYaakov Mental Health Centerlead
- Ebetim Cliniccollaborator
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 27, 2008
First Posted
May 30, 2008
Study Start
June 1, 2008
Primary Completion
January 1, 2009
Study Completion
January 1, 2009
Last Updated
January 27, 2009
Record last verified: 2009-01